Literature DB >> 3913869

Multiple sclerosis: Indian experience in the last thirty years.

S Jain, M C Maheshwari.   

Abstract

A total of 354 cases of multiple sclerosis (MS) were collected from various published reports from India over the last three decades. MS is definitely an uncommon disease in India. Certain clinical characteristics, previously noted individually, have been confirmed to exist in India. When compared to MS in Western countries, the Indian cases show a relatively high incidence of optic nerve involvement (both at the onset and during the course of the disease). Neuromyelitis optical is also seen more frequently. MS may be more common in northern as compared to southern India. In isolated studies HLA-B12 has been reported to be associated with MS in India and positive CSF oligoclonal bands have been seen in only 30% of the cases.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3913869     DOI: 10.1159/000110220

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  14 in total

1.  Management of optic neuritis.

Authors:  Vimla Menon; Rohit Saxena; Ruby Misra; Swati Phuljhele
Journal:  Indian J Ophthalmol       Date:  2011 Mar-Apr       Impact factor: 1.848

2.  Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis.

Authors:  G Dean; M Elian
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-11       Impact factor: 10.154

3.  Aquaporin 4 antibody [NMO Ab] status in patients with severe optic neuritis in India.

Authors:  Selvakumar Ambika; Mahalakshmi Balasubramanian; Lily Theresa; Akila Veeraputhiran; Deepak Arjundas
Journal:  Int Ophthalmol       Date:  2015-02-15       Impact factor: 2.031

4.  Adenosine deaminase and 5'nucleotidase activities in peripheral blood T cells of multiple sclerosis patients.

Authors:  S Vivekanandhan; C C Soundararajan; M Tripathi; M C Maheshwari
Journal:  Neurochem Res       Date:  2005-04       Impact factor: 3.996

Review 5.  Epidemiologic evidence for multiple sclerosis as an infection.

Authors:  J F Kurtzke
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

6.  Insights into the changing perspectives of multiple sclerosis in India.

Authors:  Lekha Pandit
Journal:  Autoimmune Dis       Date:  2011-06-08

7.  'Beta-interferons' and 'oligoclonal bands' in multiple sclerosis in India.

Authors:  K M Hassan
Journal:  Ann Indian Acad Neurol       Date:  2011-04       Impact factor: 1.383

8.  Optimizing the management of neuromyelitis optica and spectrum disorders in resource poor settings: Experience from the Mangalore demyelinating disease registry.

Authors:  Lekha Pandit; Sharik Mustafa; Ramya Kunder; Rajesh Shetty; Zulkifly Misri; Shivanand Pai; Rakshith Shetty
Journal:  Ann Indian Acad Neurol       Date:  2013-10       Impact factor: 1.383

Review 9.  Epidemiology and genetic aspects of multiple sclerosis in India.

Authors:  Rohit Bhatia; Prerna Bali; Rima M Chaudhari
Journal:  Ann Indian Acad Neurol       Date:  2015-09       Impact factor: 1.383

10.  Neuromyelitis optica-IgG testing in an Indian cohort with neuromyelitis optica and related demyelinating disorders: Our experience.

Authors:  Narayanan Unni; Kavita Barhate; Nisha Ahmad; Malti Ganeshan; Bhim Singhal
Journal:  Ann Indian Acad Neurol       Date:  2013-07       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.